Infant Growth

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Novo Nordisk
Novo NordiskBAGSVAERD DENMARK, Denmark
1 program
1
NIDCAPPhase 11 trial
Active Trials
NCT00388141Completed90Est. Jun 2007
Abbott
AbbottABBOTT PARK, IL
1 program
Human Milk Fortifier AN/A1 trial
Active Trials
NCT02307760Completed164Est. Feb 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Novo NordiskNIDCAP
AbbottHuman Milk Fortifier A

Clinical Trials (2)

Total enrollment: 254 patients across 2 trials

NCT00388141Novo NordiskNIDCAP

Nursing and Nurturing Premature Infants

Start: Mar 2005Est. completion: Jun 200790 patients
Phase 1Completed
NCT02307760AbbottHuman Milk Fortifier A

Evaluation of Human Milk Fortifiers in Preterm Infants

Start: Dec 2014Est. completion: Feb 2017164 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space